oxcarbazepine and caffeine
oxcarbazepine has been researched along with caffeine in 7 studies
Research
Studies (7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Beckmann, H; Berger, W; Deckert, J; Heckers, S; Heinsen, H; Kleopa, K; Ransmayr, G; Riederer, P | 1 |
Bošković, B; Prostran, MŠ; Stepanović-Petrović, RM; Tomić, MA; Ugrešić, N; Vučković, SM | 2 |
Fredholm, BB; Reid, AR; Sawynok, J | 1 |
Reviews
1 review(s) available for oxcarbazepine and caffeine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
6 other study(ies) available for oxcarbazepine and caffeine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Adenosine A1 receptors in human hippocampus: inhibition of [3H]8-cyclopentyl-1,3-dipropylxanthine binding by antagonist drugs.
Topics: Aged; Anticonvulsants; Autoradiography; Binding, Competitive; Caffeine; Carbamazepine; Female; Hippocampus; Humans; Male; Middle Aged; Oxcarbazepine; Purinergic Antagonists; Receptors, Purinergic; Xanthines | 1993 |
The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists.
Topics: Analgesics, Non-Narcotic; Animals; Caffeine; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Hyperalgesia; Male; Oxcarbazepine; Pain Measurement; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1 | 2004 |
Peripheral anti-hyperalgesia by oxcarbazepine: involvement of adenosine A1 receptors.
Topics: Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Anticonvulsants; Caffeine; Carbamazepine; Dose-Response Relationship, Drug; Drug Synergism; Functional Laterality; Hyperalgesia; Male; Oxcarbazepine; Peripheral Nervous System; Phosphoric Diester Hydrolases; Rats; Rats, Wistar; Receptor, Adenosine A1; Xanthines | 2006 |
Caffeine reverses antinociception by oxcarbazepine by inhibition of adenosine A1 receptors: insights using knockout mice.
Topics: Adenosine A1 Receptor Antagonists; Analgesics; Animals; Caffeine; Carbamazepine; Drug Antagonism; Female; Male; Mice; Mice, Knockout; Oxcarbazepine; Pain; Pain Measurement; Receptor, Adenosine A1 | 2010 |